Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and AbbVie announced today the outcome from the Phase ...

The FDA granted fast track designation to nuvisertib for those with intermediate or high-risk myelofibrosis, which ...

Around 1,500 people with multiple myeloma will benefit from belantamab mafodotin, used in combination with bortezomib and ...

A father-of-three who was initially told his rib and back pain was likely caused by a pulled muscle was left in “complete ...

Detecting cancer from a single drop of blood sounds like science fiction—but AI is making it a reality. In this episode, we dive into groundbreaking research where artificial intelligence is helping ...

Cinnamon is loaded with antioxidants and, in theory, could improve sexual functioning. Find out how cinnamon affects hormones ...

Researchers at Johns Hopkins University have discovered that cancer can be detected in the bloodstream a full three years ...

AbbVie (ABBV) stock in focus after a Phase 3 trial setback for leukemia therapy venetoclax marketed with Roche (RHHBY) in ...

"It was extremely difficult for us as her parents to have to watch our child go through these side effects knowing that there ...

The Festival of Genomics and Biodata is just around the corner, and we’ve had the opportunity to sit down with […] ...

Health evaluations for me are essential for maintaining well-being and detecting potential issues early when things are most ...